TTRX
Turn Therapeutics Inc. Common StockNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$104.26M
P/E Ratio
—
EPS
$-0.12
Beta
—
52W High
$10.00
52W Low
$2.57
50-Day MA
$3.65
200-Day MA
$4.01
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Turn Therapeutics Inc. Common Stock
Turn Therapeutics Inc., is a pharmaceuticals company that develops drugs to treat diseases of the skin, nails, and eye. The company is headquartered in Westlake Village, California.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | -496,948 |
| EBITDA | $-6.30M |
| Operating Margin | 0.00% |
| Return on Equity | -141.70% |
| Return on Assets | -55.90% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $0.02 |
| Price-to-Book | 21.05 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $29.79M |
| Float | $10.91M |
| % Insiders | 63.74% |
| % Institutions | 1.75% |
Historical Volatility
HV 10-Day
61.55%
HV 20-Day
50.64%
HV 30-Day
59.36%
HV 60-Day
68.08%
HV Rank
—
Volatility is currently expanding
Analyst Ratings
Consensus ($8.00 target)
1
BuyData last updated: 4/9/2026